Two Sigma Advisers’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Two Sigma Advisers's ONC Position: Q1 2026 in Review
Two Sigma Advisers sold out of BeOne Medicines (ONC) in Q1 2026, closing a stake of 1,575 shares — an estimated $479K sold.
Two Sigma Advisers first reported a position in ONC in Q2 2021 and held it in 3 quarters. The position peaked at $17M in Q1 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Two Sigma Advisers reported no remaining BeOne Medicines position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 1,575 BeOne Medicines shares in Q1 2026, an estimated $479K.
- Two Sigma Advisers first reported a position in BeOne Medicines in Q2 2021 and held it in 3 quarters.
- Two Sigma Advisers's BeOne Medicines position peaked at $17M in Q1 2025.
- 283 funds tracked by Wall St. Rank held BeOne Medicines as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.